ArticleScientific reports2026
Fractional spatiotemporal Hahnfeldt tumor model with convergence analysis and optimal control.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The mathematical modeling of tumor-immune interactions is pivotal for decoding the complex, multistage processes of cancer progression, yet classical integer-order models often fail to capture the hereditary properties and spatial heterogeneity intrinsic to malignant growth. This research presents a novel fractional spatiotemporal Hahnfeldt tumor model that integrates Caputo fractional derivatives with diffusion mechanisms to characterize memory dependent tumor vascular dynamics. Unlike standard formulations, this model explicitly accounts for the "biological memory" of the immune system and the "sub-diffusive" invasion patterns of tumor cells. We provide a rigorous mathematical analysis, establishing the non-negativity and boundedness of solutions, followed by a stability analysis of the Adams-Bashforth-Moulton predictor-corrector scheme. Numerical simulations reveal that lower fractional order inherently reproduce clinical phenomena such as tumor dormancy and delayed therapeutic response, which are mathematically inaccessible to integer-order counterparts. Furthermore, a fractional optimal control framework, solved via the Forward-Backward Sweep Method, demonstrates that adaptive chemo-immunotherapy significantly outperforms monotherapies by leveraging the system's memory to sustain remission. These findings offer a theoretically sound and clinically relevant computational tool for predicting long-term treatment outcomes in heterogeneous tissue environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.